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Abstract Parkinson’s disease (PD) does not manifest
clinically until 80 % of striatal dopamine is reduced, thus
most neuronal damage takes place before the patient pre-
sents clinical symptoms. Therefore, it is important to
develop preventive strategies for this disease. In the
experimental models of PD, 1-methyl-4-phenylpyridinium
ion (MPP?) and rotenone induce toxicity in dopaminergic
neurons. Neuroprotectin D1 (NPD1) displays neuropro-
tection in cells undergoing proteotoxic and oxidative stress.
In the present report, we established an in vitro model
using a primary neuronal culture from mesencephalic
embryonic mouse tissue in which 17–20 % of neurons
were TH-positive when differentiated in vitro. NPD1
(100 nM) rescued cells from apoptosis induced by MPP?
and rotenone, and the dendritic arbor of surviving neurons
was examined using Sholl analysis. Rotenone, as well as
MPP? and its precursor 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), severely promoted retraction
of dendritic arbor distal segments, thus decreasing the
maximum branch order reached. On average, NPD1
counteracted the effects of MPP? on the dendritic
arborization, but failed to do so in the rotenone-treated
neurons. However, rotenone did decrease the Sholl inter-
section number from radii 25 to 125 lm, and NPD1 did
restore the pattern to control levels. Similarly, NPD1
partially reverted the dendrite retraction caused by MPP?
and MPTP. These results suggest that the apoptosis
occurring in mesencephalic TH-positive neurons is not a
direct consequence of mitochondrial dysfunction alone and
that NPD1 signaling may be counteracting this damage.
These findings lay the groundwork for the use of the
in vitro model developed for future studies and for the
search of specific molecular events that NPD1 targets to
prevent early neurodegeneration in PD.
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Introduction
Parkinson’s disease (PD) does not manifest clinically until
80 % of the striatal dopamine has been lost (Betarbet et al.
2002). Therefore, it is vital to develop strategies that pre-
vent the loss of dopamine neurons.
Until recently, the significance of the selective enrich-
ment of omega-3 essential fatty acids (docosahexaenoyl—
DHA—chains of membrane phospholipids, 22C and 6
double bonds) in the nervous system had remained incom-
pletely understood (Bazan et al. 2011; Bazan 2014). We now
know that an integral membrane protein is engaged in DHA
retention in photoreceptors/retinal pigment epithelial cells as
a necessary event for the function of these cells (Rice et al.
2015). By studying early mechanisms of cell survival, we
found that a docosanoid synthesized from docosahexaenoic
acid (DHA) by 15-lipoxygenase-1 (15-LOX-1), neuropro-
tectin D1 (NPD1; 10R,17S-dihydroxy-docosa-4Z,7Z,11E,13
E,15E,19Z hexaenoic acid) (Bazan et al. 2010; Calandria
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et al. 2009; Serhan et al. 2015), displays neuroprotective
bioactivity. Moreover, NPD1 prevents apoptosis induced by
oxidative stress (Calandria et al. 2009, 2012) involving
transcriptional regulation (Calandria et al. 2015). Previously,
it has been shown in experimental models of PD that MPP?
and rotenone inhibit the Complex I of the mitochondrial
electron chain and causes specific toxicity to dopaminergic
neurons in the substantia nigra pars compacta (SNpc) (Be-
tarbet et al. 2000; Davis et al. 1979; Langston et al. 1983;
Richardson et al. 2005).
The goal of this study was to develop an in vitro model
of PD where lipid mediators could be studied in a direct
manner and to determine the ability of NPD1 to enhance
survival during early toxicity in mesencephalic TH-posi-
tive neurons. We used a onetime application of 1-methyl-4-
phenylpyridinium ion (MPP?), 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), or rotenone, measuring sur-
vival and dendritic architecture modification in the
remaining neurons after 24 h. In this manner, we estab-
lished a cellular model to reenact the first toxic event that




Animals were handled following protocols on animal
experimentation approved by the Institutional Animal
Care and Use Committee (IACUC), Louisiana State
University Health Sciences Center (LSUHSC), New
Orleans. Culture media, additives and other related
reagents, including trypsin and B-27/N2, were purchased
from Life Technologies (Carlsbad, CA). Fetal bovine
serum (FBS) was acquired from Tissue Culture Biologi-
cals (Long Beach, CA), and glial cell line-derived neu-
rotrophic factor (GDNF) and transforming growth factor
beta (TGF-b) were from Cell Sciences (Canton, MA).
DNAseI, dbcAMP, MPTP, MPP? and rotenone were
obtained from Sigma (St. Louis, MO). Anti-tyrosine
hydroxylase antibody was purchased from Pel-Freez
(Rogers, AR); anti-b-tubulin III was from Sigma (St.
Louis, MO) and anti-Map2 from Millipore (Billerica,
MA). Secondary antibodies conjugated with Alexa Fluor
488 and 555 and nuclei staining DAPI were obtained
from Life Technologies (Carlsbad, CA).
Rat Mesencephalic TH-Positive Neurons: Primary
Culture, Treatment, and Immunocytochemistry
The cultures were performed following the methods
described previously (Sun et al. 2004) with some
modifications. Briefly, 1 mm3 of the ventricular mesen-
cephalic region was obtained from Sprague–Dawley rat
embryos (embryonic day 15). Two incisions were made,
one in the forebrain/mesencephalic limit and the other
between the mesencephalon and the hindbrain. Once dis-
sected from the meninges, the tissue was disaggregated
using trypsin and DNaseI. Twenty thousand cells were
plated in each well of an 8-well chamber slide with B-27/
N2 medium containing 2.5 % serum. GDNF, TGF-b, and
dcAMP were added once to increase TH-positive cells
(Supplementary Fig. 1) and the media were changed every
2 days. The percentage of TH-positive cells achieved was
17–20 %. NPD1 (100 nM) was added to the culture at 7
DIV, 5 min before the addition of 100 nM rotenone,
100 lM MPP? or 100 lM MPTP. To decide the time of
exposure to MPTP and rotenone, 24- and 48-h time points
were used (Supplementary Figs. 2, 3). Immunostaining was
performed following a previously described protocol (Ca-
landria et al. 2012). Briefly, cells were fixed with 4 %
paraformaldehyde, permeabilized with 1 % Triton and 1 %
normal serum in phosphate buffered saline (PBS) for
5 min, and then blocked with 10 % normal serum solution
in PBS. The slides were incubated with the primary anti-
body overnight and then for 1 h with Alexa fluor-conju-
gated secondary antibodies.
Image Acquisition, Assessment of the Dendritic
Arbor, and Statistics
Images were obtained using a custom-built deconvolution
microscope and Slidebook 4.0 software (3i-Intelligent
Imaging Innovations, Inc., Denver, CO). Images were
imported and analyzed using the software Imaris 7.4 (Bit-
plane Scientific Software, Ireland, UK) or NeuronJ (Mei-
jering et al. 2004) plugged into ImageJ (Rasband 1997–
2014). The intersection frequencies of Sholl analysis were
plotted and analyzed statistically to fit a polynomial regres-
sion to assess the statistically significant differences between
treatments within an experiment (Supplementary Table 1;
Fig. 2q). The Sholl values were used to construct a frequency
histogram and compared between treatments within each
class interval and between intervals using Student’s t test
(Tables 1, 2). The statistical analysis was performed using
the SAS software (SAS Institute, Cary, NC).
Results
TH-Positive Neuron Cell Death Triggered
by Rotenone and MPP1 is Prevented by NPD1
Rotenone and the MPTP metabolite, MPP?, was proposed
to induce toxicity primarily by blocking mitochondrial
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Complex I, which results in the production of superoxide
radicals and consequently, oxidative stress (Ramachandi-
ran et al. 2007). To determine the ability of NPD1 to
prevent cell death induced by these three compounds,
mesencephalic primary-cultured neurons were exposed to
100 nM rotenone, 100 lM MPTP, or 100 lM MPP? in the
presence and absence of NPD1 for 24 h (Fig. 1a–c). MPP?
severely decreased the number of TH-positive neurons
from 40.3 ± 7.3 in the control to 7.6 ± 1.6; with the
addition of NPD1, the number of surviving cells was raised
to 14.4 ± 2.7 (Fig. 1b). MPTP, the precursor of MPP?,
also displayed toxicity, promoting the disappearance of
65.7 % of the TH-positive neurons, but this effect was not
significantly counteracted by NPD1 (Fig. 1b). On the other
hand, rotenone reduced the TH-positive neuronal popula-
tion 63 %, and NPD1 reversed that effect almost com-
pletely (Fig. 1c). The NPD1 stereoisomer (10S,17S-
diHDHA) had no effect on TH-positive cell survival,
indicating that the protection was specifically induced by
the S/R stereoisomer (Figs. 1c, 2o, p).
Neurons That Survived with the Addition of NPD1
Showed Better Dendritic Morphology on Average
Mitochondrial damage and depletion leads to neurite
retraction or shortening (Cherra et al. 2013). We analyzed the
dendritic arbors of surviving TH-positive neurons to evalu-
ate whether NPD1 addition affected neurite integrity. Gen-
eral features were assessed, including maximum dendritic
order reached for each TH-positive neuron, number of den-
drite segments and branches, the sum of all the segment
lengths for each neuron, and the mean for the dendrite
diameters. MPTP and MPP? only altered the parameters
related to the length of the dendrites and not related to their
thickness, as shown in Fig. 1d–m. Overall, the integrity of
the dendritic arbor was best preserved in cells treated with
NPD1 in comparison with the ones that survived without
NPD1 treatment (Fig. 1d–m). Although more TH-positive
neurons survived the rotenone treatment with the addition of
NPD1 (Fig. 1c), there was no difference in the maximum
dendritic order, the number of segments, or the combined
length of all branches and segments when neurons were
treated with the lipid mediator (Fig. 1n, o, q). Intriguingly,
the number of branches (Fig. 1p) on average did not show
any significant changes in rotenone-treated TH-positive
neurons when compared to controls, suggesting a different
mechanism of toxicity. On the contrary, MPP? induced a
reduction in length and number of branches (Fig. 1d, f, h, j,
l), and these effects were reversed almost completely by
NPD1. MPTP produced an outcome similar to MPP?,
although NPD1 did not provide the same level of improve-
ment (Fig. 1e, g, i, k, m).
2D Analysis of Dendritic Branching shows
that NPD1 prevents Neurite Retraction at Short
to Medium Radii
The Sholl number is the frequency by which neurites
intersect in concentric circles drawn around the soma at
different radii (Fig. 2b). To further visualize spatially the
alterations introduced by MPP? and its precursor MPTP or
rotenone, the total number of Sholl intersections per
treatment were averaged and plotted versus the radius
(Fig. 2a, e, i). Two-way ANOVA showed significant dif-
ferences between treatments (Supplementary Tables 2, 3).
The Sholl values were fit to a polynomial curve using the
least squares model (Supplementary Table 1; Fig. 2q). To
assess the distances from the soma at which the differences
occurred in the dendritic tree, the curves were broken down
into six class intervals containing radii from 0 to 25, 26 to
50, 51 to 75, 76 to 100, 101 to 125, and 126 to 150 lm
(Tables 1, 2). Pairwise comparisons between treatments in
each interval showed that MPP? induced a consistent and
significant decrease in neurites at all radii and that this
effect was totally reversed by NPD1 within the interval
from 0 to 25 lm and partially from radius 26 lm or over
(Table 1). MPP?- and MPTP-treated neurons showed
significant differences, in the presence and absence of
NPD1, for radii 0–125 lm (Table 1; Fig. 2a, e). On the
other hand, NPD1 stereo-specifically reversed rotenone-
induced reduction in the Sholl number at radii 25–100 lm
(Fig. 2i; Table 2). Altogether, these results suggest that
MPP? and rotenone exert their toxicity through different
mechanisms and that NPD1 halts damage caused by rote-
none and MPP? to TH-positive neurons.
Terminal Neurites are protected from MPP1
Toxicity by NPD1
Total and terminal number of dendrites were plotted versus
the dendritic order to assess the location of damage within
the dendritic tree. On average, the total dendritic segments
were decreased from 24.9 ± 2 in the control to 8.1 ± 1 in
neurons treated with MPP? (Fig. 3a), and the average
terminal number of segments followed the same trend
(Fig. 3c). The vehicle control DMSO showed a reduction
of about 30 % in total segments (Fig. 3a). The number of
total and terminal segments started to decline at the den-
dritic order 2 for the MPP?-treated neurons, and the
greatest difference in numbers was reached at dendritic
order 3. NPD1 was more effective in protecting dendritic
segments at order 2. Following that order, even in the
presence of NPD1, the number of total segments was
reduced significantly in comparison with the control
(Fig. 3b). Terminal branches behaved in a different way. In
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Fig. 1 NPD1 promotes survival and prevents dendrite dystrophy of
dopaminergic neurons upon addition of MPTP, MPP?, and rotenone.
a–c Neuron survival was measured by a direct count of tyrosine
hydroxylase-positive neurons per random field by triplicate per well
in at least two wells per condition in two independent experiments.
a Representative images of mesencephalic neuronal culture neurons
stained with MAP2 (red first column) and tyrosine hydroxylase (green
second column); nuclei are blue. b, c Tyrosine hydroxylase-positive
cells after 24-h 100 lM MPP? or 100 lM MPTP (b) and 100 nM
rotenone (c) treatment in the presence or absence of 100 nM NPD1
(b, c) or 10S–17S-diHDHA stereoisomer (c). d–m Neurons that
survived MPP? or MPTP in the presence of NPD1 showed a better
dendritic architecture than those that were not treated with NPD1. d,
e Maximum dendritic order, f, g number of segments, h, i number of
branches, j, k sum of the length of all the segments per neuron, and l,
m the mean diameter of the dendrites in MPP?- (d, f, h, j, l) or
MPTP- (e, g, i, k, m) treated cells in the presence or absence of
NPD1. DMSO was added as vehicle control. Isolated TH-positive
neurons from three random fields per well in two wells per
experiment were traced using IMARIS 7. Two experiments were
pooled together. n–r TH-positive neurons that survived 100 nM
rotenone treatment for 24 h: n maximum dendritic order, o number of
segments, p number of branches, q sum of the length of all the
segments per neuron, and r the mean diameter of the dendrites. Total
neurons included for d, f, h, j, l were control N = 22, DMSO N = 11,
MPP? N = 25, and MPP? ? NPD1 N = 37. For e, g, i, k, m:
control N = 23, DMSO N = 16, MPP? N = 17 and
MPP? ? NPD1 N = 30. For n–r, control N = 10, rotenone ?,
rotenone ? NPD1 N = 33, and rotenone alone N = 18. Bars repre-
sent the mean ± SEM. *P\ 0.05, NS non-significant P value
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control cells, a lesser proportion of primary neurites was
terminal (Fig. 3c, d). Consistent with the effect of the
terminal segments that induced their retraction, the order at
which the curve peaked was lower with MPP?, so this was
the order at which the values became zero; this means the
most abundant terminal neurites were located at order 2,
and there were no dendrites at order 6. Once again, NPD1-
treated neurons presented dendritic arbor architecture
similar in configuration to that of the vehicle, as well as a
preserved maximum distal dendrite order.
Altogether, these results suggest that the damage caused
by MPP? induces a diminished arborization, which is a
product of terminal neurite retraction. The addition of
NPD1 reversed the damage produced by MPP?, bringing
the number of dendrites back to the levels of vehicle-
treated neurons.
Discussion
NPD1 is a docosahexaenoic acid derivative shown to be
protective in neurons and RPE cells undergoing pro-
teotoxic and oxidative stress damage (Mukherjee et al.
2004; Calandria et al. 2012) as well as in other dysruptions
of homeostasis (Bazan et al. 2011). Here we report specific
NPD1 effects on the survival and dendrite architecture of
Fig. 2 NPD1 prevents disruption of dendritic architecture caused by
MPP?, MPTP, or rotenone. The dendritic architecture was assessed
using Sholl analysis, which involves calculating the frequency at
which the dendritic arbor intersects a series of concentric circles
separated by 1 lm using the soma as the center (b right panel). a,
e Sholl number of intersections (averaged) versus radius of neurons
treated with a MPTP, e MPP? and i rotenone in the presence or
absence of NPD1. In all cases, comparisons were made against non-
treated neurons (control). The curves were fitted to a polynomial
regression model using a least squares regression model
(P\ 0.0001); see Supplementary Tables 1–5 and Supplementary
Fig. 4. b–d, f–m Right and left panels show a neuron and its
corresponding tracings as an output of the IMARIS software,
respectively. b, f, j Control neurons or treated with c, d 100 lm
MPTP; g, h 100 lm MPP?; k–m rotenone 100 nM; d, h, m plus of
NPD1 or l its S–S stereoisomer. The values are represented as the
mean ± SEM. NS non-significant P value. n, o Molecular structure of
n DHA; o 10S-17S-diHDHAstereoisomer and p NPD1. q Polynomial
regression model for MPP? and MPTP Sholl intersections. The
mathematical formulas for the curves plotted are described in
Supplementary Table 1. Isomer: 10S,17S-diHDHA
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TH-positive cells exposed to MPTP, its metabolite MPP?,
or rotenone. NPD1 increased the survival of TH-positive
cells treated with MPP? (Fig. 1b) or rotenone (Fig. 1c).
MPTP treatment did not reduce the neuron population to
the same extent, and NPD1-mediated neuroprotection was
not as strong as with the other two toxins (Fig. 1b).
Interestingly, MPTP toxicity was not reversed by NPD1 to
the same extent as MPP?, suggesting that both actions are
executed by different mechanisms. MPTP conversion to
MPP? and release occurs in glial cells (Ransom et al.
1987). It may be possible that this processing of MPTP
delays and decreases the amount of MPP? that reaches
Table 1 Sholl intersection number mean under least squares model
Radius (lm) Treatment Sholl least squares
mean









DMSO 4.24888889 0.07223875 0.0263
MPP? 2.61000000 0.07223875 \0.0001 \0.0001
MPP? ? NPD1 3.61272727 0.07223875 0.9678
MPTP 3.59000000 0.07223875 0.8977 0.0003




DMSO 4.35111111 0.07223875 \0.0001
MPP? 1.56000000 0.07223875 \0.0001 \0.0001
MPP? ? NPD1 4.02727273 0.07223875 \0.0001
MPTP 2.26500000 0.07223875 \0.0001 \0.0001




DMSO 4.10666667 0.07223875 0.0003
MPP? 0.96000000 0.07223875 \0.0001 \0.0001
MPP? ? NPD1 3.25090909 0.07223875 \0.0001
MPTP 1.04000000 0.07223875 \0.0001 \0.0001




DMSO 2.45333333 0.07223875 \0.0001
MPP? 0.59000000 0.07223875 \0.0001 \0.0001
MPP? ? NPD1 1.75090909 0.07223875 \0.0001
MPTP 0.55000000 0.07223875 \0.0001 \0.0001




DMSO 0.92444444 0.07223875 \0.0001
MPP? 0.27000000 0.07223875 \0.0001 \0.0001
MPP? ? NPD1 0.94363636 0.07223875 \0.0001
MPTP 0.37500000 0.07223875 \0.0001 0.0129




DMSO 0.21333333 0.07223875 0.0003
MPP? 0.12500000 0.07223875 \0.0001 0.9284
MPP? ? NPD1 0.36363636 0.07223875 \0.0001
MPTP 0.34500000 0.07223875 \0.0001 1.000
MPTP ? NPD1 0.44727273 0.07223875 \0.0001
Mesencephalic neurons were treated with MPTP and MPP? in the presence or absence of NPD1. The Sholl intersections numbers are shown for
TH-positive neurons that survived the 24-h treatment. Data were broken down into 6 class intervals of 25-lm radius (left column) and the mean
and standard error of the mean were fitted to the least squares regression model (columns 3, 4). The Scholl least squares mean values were
compared pairwise against the control (column 5) and between samples in the presence or absence of NPD1 (column 6)
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neurons, thus causing a weaker but sustained damage
compared to the acute insult produced by MPP?. This may
explain the differences in TH-positive neurons survival and
the protection exerted by NPD1 (Fig. 1b).
Here we report an 81 % disappearance of TH-positive
neurons (from 40.3 ± 7.3 in the control to 7.6 ± 1.6 in
MPP?-treated neurons). MPP? selectively damages cells
expressing DAT (Holzschuh et al. 2001), and at least 81 %
of the TH-positive cells (17–20 % of the total neuronal
population) are dopaminergic neurons. Consequently, the
majority of cells rescued from death by NPD1 were also
dopaminergic. We cannot discount, however, the presence
of other catecholaminergic cells. In fact, damage in the
noradrenergic system increases dopaminergic neurotoxicity
in MPTP-treated primate and MPTP-treated rodent animal
models (Fornai et al. 1997); however, there is no clear
evidence that non-dopaminergic neurons in culture reacts
to MPP?.
DHA decreases caspase-dependent actin cleavage at
dendrites when neurons undergo oxidative stress (Calon
et al. 2004). Also, under oxidative stress conditions, DHA
is converted into NPD1 (Calandria et al. 2009) and the
latter decreases caspase activation in neurons (Calandria
et al. 2012; Mukherjee et al. 2004).
The neurons surviving MPTP or MPP? treatments
showed, on average, a decrease in dendrite order and
number of dendritic segments, as well as reduced branch-
ing (Fig. 1d–k). Rotenone affected the dendritic order and
number of segments (Fig. 1n, o, q) but did not affect the
number of branches (Fig. 1p). Accordingly, the extent and
pattern of the damage displayed in the assessment of Sholl
intersections differed significantly from MPTP/MPP? and
rotenone, suggesting specific mechanisms of action for
both types of toxins.
MPP?, a metabolite of MPTP, induces damage in SNpc
dopaminergic neurons. Although it is not known why this
Table 2 Sholl intersection number mean under least squares model












Control 3.566087 0.050271 3.56608696 0.05458508
Rotenone ? NPD1 3.053846 0.051608 3.17600000 0.06257759 0.0006
Rotenone 3.176552 0.054958 3.17655172 0.06874702 0.0021
Rotenone ? isomer 3.069712 0.04671 3.24434783 0.05458508 0.0061
26–50 class
Interval 2
Control 3.655652 0.048947 3.65565217 0.05458508
Rotenone ? NPD1 3.889143 0.07469 3.88914286 0.06257759 0.4237
Rotenone 2.732414 0.07011 2.73241379 0.06874702 \0.0001
Rotenone ? isomer 2.709135 0.053452 2.74869565 0.05458508 \0.0001
51–75 class
Interval 3
Control 3.153043 0.059304 3.15304348 0.05458508
Rotenone ? NPD1 3.245714 0.08262 3.24571429 0.06257759 1.0000
Rotenone 1.964138 0.066669 1.96413793 0.06874702 \0.0001
Rotenone ? isomer 1.860833 0.050282 1.89130435 0.05458508 \0.0001
76–100 class
Interval 4
Control 2.726957 0.066676 2.72695652 0.05458508
Rotenone ? NPD1 2.745143 0.080876 2.74514286 0.06257759 1.0000
Rotenone 1.445517 0.060717 1.44551724 0.06874702 \0.0001
Rotenone ? isomer 1.236667 0.049299 1.25739130 0.05458508 \0.0001
100–125 class
Interval 5
Control 2.222609 0.066566 2.22260870 0.05458508
Rotenone ? NPD1 1.816 0.058925 1.81600000 0.06257759 \0.0001
Rotenone 1.157241 0.071509 1.15724138 0.06874702 \0.0001
Rotenone ? isomer 0.814167 0.038327 0.82782609 0.05458508 \0.0001
126–150 class
Interval 6
Control 1.848696 0.064044 1.84869565 0.05458508
Rotenone ? NPD1 1.313143 0.057406 1.31314286 0.06257759 \0.0001
Rotenone 0.982069 0.06284 0.98206897 0.06874702 \0.0001
Rotenone ? isomer 0.648333 0.034167 0.66173913 0.05458508 \0.0001
Mesencephalic neurons were treated with 100 nM rotenone in the presence or absence of NPD1. The Sholl intersections numbers are shown for
TH-positive neurons that survived the 24-h treatment. Data were broken down into 6 class intervals of 25-lm radius (left column) and the mean
and standard error of the mean (columns 3, 4) were fitted to the least squares regression model (columns 5, 6). The Sholl least squares mean
values were compared pairwise against the control (column 7). Isomer: 10S,17S-diHDHA
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metabolite prefers SNpc neurons specifically, it was pro-
posed that MPP? is internalized by neurons through the
dopamine transporter DAT and that it may induce oxida-
tion of intracellular dopamine, which confers dopaminergic
neuronal specificity to the toxin (Holzschuh et al. 2001). It
was proposed that MPP? inhibits mitochondrial Complex
I, enhancing the production of reactive oxygen species
(ROS) (Cleeter et al. 1992) and inducing a mild depletion
in ATP (Chan et al. 1991), features observed in PD post-
mortem brains (Parker et al. 1989; Schapira et al. 1990;
Keeney et al. 2006).
Other lines of evidence contradict the Complex I
hypothesis. For instance, midbrain mesencephalic-cultured
dopaminergic neurons that lack Ndufs4, a key assembly
subunit in Complex I and thus a functional Complex I, have
survived and shown normal morphology (Choi et al. 2008).
These neurons displayed more sensitivity to rotenone and
MPP? than the Ndufs4?/? dopaminergic neurons. Fol-
lowing this line of thought, it was recently proposed that
microtubule dysfunction may be the mechanism responsible
for the rotenone effect on dopaminergic cells, and the lack of
functional Complex I may potentiate this toxicity (Choi et al.
2011). It also was shown that MPP? (Cappelletti et al. 2005;
Cartelli et al. 2010) and rotenone (Choi et al. 2011) have an
effect on the cytoskeleton that may provide an explanation
for the shrinkage of the dendritic tree. Since microtubular
dysfunction affects neuronal survival in different ways, it
may be an early indicator of neurodegeneration. For
instance, autophagy, a microtubular-dependent mechanism
during stress conditions (Mackeh et al. 2013), clears dam-
aged mitochondria to prevent toxicity. This process is called
mitophagy and is regulated by PINK (Ashrafi and Schwarz
2013), involved in hereditary PD (Valente et al. 2004).
Furthermore, autophagy was found to be compromised in
conditional ATG7 knockout mice, with a subsequent
decrease of dopaminergic neurons in the SNpc and an
accumulation of a-synuclein and LRRK2 (Friedman et al.
2012). Our results indicate that terminal dendrites are com-
promised in MPP?-surviving TH-positive neurons (Fig. 3).
Dendritic dystrophy, a reduction in length and complexity of
dendrites, is a common feature of neurodegeneration, most
often observed in PD (Friedman et al. 2012). Although in our
cellular model, no morphological signals of initial dendro-
toxicity, such as neurite beading, were observed after 24 h of
treatment, the disappearance of terminal segments
(Figs. 1d–g, j–k, n–o, q, 3) and diminished branching
occurred (Figs. 1h–i, 2a, e, i) in response to MPTP, MPP?
and rotenone. In the Drosophila’s larval multidendritic
neuron model, dendrite degeneration is an active pro-
grammed process that can take place within the first 24 h of
toxic exposure (Tao and Rolls 2011). This timing may
explain the absence of dendritic beading observed.
Protein phosphate 2A (PP2A) is a master regulator of the
phosphorylation/dephosphorylation processes, including
Fig. 3 Terminal dendrites are
preserved with NPD1 treatment.
TH-positive neurons were
traced using a NeuronJ plug-in
of ImageJ. a, c Average of the
dendritic order. b, d Average of
segments for each dendritic
order (a, b) and terminal
dendrites (c, d) in control,
DMSO- or MPP?-treated cells,
the latter in the presence or
absence of NPD1. The values
are represented as the
mean ± SEM. *P\ 0.05. NS
non-significant P value
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microtubule stabilization/destabilization. Recently, NPD1
modulates PP2A activity (Antony et al. 2010; Calandria et al.
2012). Furthermore, PP2A was involved in the microtubular
dysfunction related to tauopathies present in Alzheimer’s
disease (Sontag et al. 2012) and also found in postmortem PD
brains (Wills et al. 2010). Therefore, the pro-survival activity
of NPD1 also may be preventing dendrite retraction.
Taken together, our results suggest that NPD1 promotes
survival and preservation of the dendritic tree in dopamin-
ergic neurons undergoing MPP? or rotenone toxicity by
preventing microtubular dysfunction and oxidative stress-
driven cell death. The mechanisms by which NPD1 coun-
teracted TH-positive apoptosis and dendrite dystrophy trig-
gered by MPP? and rotenone may involve the activation of
PP2A and the inhibition of effector caspases. These findings
lay the groundwork for understanding how NPD1 signaling
may be manipulated to improve the survival of SNpc
dopaminergic cells in preclinical stages of PD and to prevent
the progression of neurodegeneration. In future studies,
efforts will be made to identify the therapeutic targets using
this information. In this way, it may be possible to promote
NPD1 signaling at early stages in at-risk populations to
reduce the incidence, delay the onset, or lessen the severity of
the symptoms later in life by preventing—at least to some
extent—dopaminergic cells from dying.
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